MedXY
Not signed in Sign in / Register
Skip to content
medxy logo Medxy AI
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • Specialties
    • Allergy & Immunology
    • Anesthesiology
    • Cardiology
    • Critical Care
    • Dermatology
    • Diabetes & Endocrinology
    • Emergency Medicine
    • Family Medicine & Nutrition
    • Gastroenterology
    • General Surgery
    • Hematology-Oncology
    • HIV/AIDS
    • Infectious Diseases
    • Internal Medicine
    • Nephrology
    • Neurology
    • Nursing & care
    • OB/GYN & Women’s Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otorhinolaryngology
    • Pathology & Lab Medicine
    • Pediatrics
    • Plastic Surgery
    • Psychiatry
    • Public Health
    • Radiology
    • Respiratory
    • Rheumatology
    • Urology
  • Clinical Updates
  • Medical News
  • iDoctor
  • facebook.com
  • twitter.com
  • t.me
  • instagram.com
  • youtube.com
Subscribe

Veterans Affairs

  • Home
  • Veterans Affairs
Evaluating the Impact of the MISSION Act on VA Specialty Care Referrals and Wait Times: A National Cohort Study
Posted inInternal Medicine news Public Health

Evaluating the Impact of the MISSION Act on VA Specialty Care Referrals and Wait Times: A National Cohort Study

Posted by By MedXY 08/27/2026
Following the 2018 MISSION Act expansion, VA specialty referrals and community care outsourcing increased substantially without reducing outpatient specialty wait times, signaling the need for alternative access-improvement strategies.
Read More
Expanding Contraceptive Access in Veterans Affairs: Pharmacist-Led Hormonal Contraception Provision and 12-Month Dispensing Pilot
Posted inInternal Medicine news OB/GYN & Women’s Health

Expanding Contraceptive Access in Veterans Affairs: Pharmacist-Led Hormonal Contraception Provision and 12-Month Dispensing Pilot

Posted by By MedXY 07/12/2026
A VA pilot study shows that pharmacist-led provision and 12-month dispensing of hormonal contraception is feasible, improves access, and enhances satisfaction among women Veterans and pharmacists.
Read More
  • Discovery of a Novel B-ALL Subtype Defined by IGH::FENDRR Rearrangement and KRAS Mutations With Poor Chemotherapy Response
  • Fecal Microbiota Transplantation: A Promising Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
  • Evaluating the Impact of the MISSION Act on VA Specialty Care Referrals and Wait Times: A National Cohort Study
  • Relapse Trajectories and Antipsychotic Discontinuation in Schizophrenia: Insights from a Meta-Analysis and Contemporary Evidence
  • Optimizing Heart Failure with Reduced Ejection Fraction Management: Insights from Swedish Registry on Quadruple Therapy Adherence and Persistence
  • About us
  • Contact us
  • MedXY story
  • Privacy Policy
  • Subscribe Now!
  • 账号
  • English
  • 日本語
  • Tiếng Việt
  • 中文

Alzheimer's disease artificial intelligence atrial fibrillation biomarkers breast cancer Cardiology cardiovascular disease cardiovascular risk chronic kidney disease clinical trial clinical trials critical care diabetes epidemiology GLP-1 receptor agonists heart failure hepatocellular carcinoma Hypertension immunotherapy inflammation MASLD mental health Mortality myocardial infarction nutrition obesity older adults oncology Pediatrics precision medicine Pregnancy prognosis prostate cancer public health quality of life randomized clinical trial randomized controlled trial risk stratification semaglutide SGLT2 inhibitors stroke type 1 diabetes type 2 diabetes weight loss women's health

Your health, we care

Copyright 2026 — Medxy AI. All rights reserved.
Scroll to Top